DAWN™ newsGlobal Result Meeting
Representatives of key international and national diabetes organizations, clinicians, researchers, people with diabetes and their family members gathered in Copenhagen on the 2ndand 3rd of November this year to review the initial results of the study. These people are all committed to supporting the wider implementation of the study’s results.
The meeting was hosted by the key global partners of DAWN2™: the International Diabetes Federation (IDF), the International Alliance of Patients’ Organizations (IAPO), the Steno Diabetes Center and Novo Nordisk. During the meeting, members of the DAWN2™ International Publication Planning Committee (IPPC) presented the initial results of the global study.
Celebrating the 10th anniversary of the DAWN study, a new book looks in detail at its achievements and the wide range of initiatives all over the world that it has inspired.
At the EASD conference in Lisbon, Portugal Novo Nordisk was proud to announce the launch of a the new and unique global study, DAWN2. The study aims to gain a 360°perspective on life with diabetes. DAWN2 will engage key stakeholders in finding new ways to enable people with diabetes to live full, healthy lives and be actively involved in managing their own health.
Dr. Mark Peyrot, an internationally recognized professor of sociology from the US who shared his views on the unique prospects of DAWN2.
Children and their parents were gathered at Tokyo’s Komatsugawa Sakura Hall for a one-day diet and exercise event arranged by the Japan Association for Diabetes Education and Care (JADEC).10 years anniversary of DAWN celebrated in Germany
The 10 years anniversary of DAWN is approaching and for this occasion a large event was held in Germany with leading expert speakers on DAWN.